tiprankstipranks
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market
ASTRAZEN
AstraZeneca Pharma India Limited
RESEARCH TOOLSreports
Want to see IN:ASTRAZEN full AI Analyst Report?

AstraZeneca Pharma India Limited (ASTRAZEN) Ratios

33 Followers

AstraZeneca Pharma India Limited Ratios

IN:ASTRAZEN's free cash flow for Q2 2026 was ₹0.42. For the 2026 fiscal year, IN:ASTRAZEN's free cash flow was decreased by ₹ and operating cash flow was ₹0.13. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.87 1.91 2.61 2.18 2.12
Quick Ratio
 0.87 1.13 1.97 1.68 1.70
Cash Ratio
 0.51 0.76 1.42 1.30 1.35
Solvency Ratio
 0.30 0.21 0.48 0.29 0.23
Operating Cash Flow Ratio
 -0.08 0.09 0.08 0.15 0.30
Short-Term Operating Cash Flow Coverage
 0.00 10.41 15.40 16.56 27.92
Net Current Asset Value
₹ 6.40B₹ 5.95B₹ 5.67B₹ 4.39B₹ 3.60B
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 <0.01 <0.01 0.01
Debt-to-Equity Ratio
 0.04 0.05 <0.01 0.01 0.02
Debt-to-Capital Ratio
 0.04 0.04 <0.01 0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 2.02 1.97 1.51 1.67 1.67
Debt Service Coverage Ratio
 78.18 20.31 59.02 28.00 17.43
Interest Coverage Ratio
 79.12 147.13 142.86 236.33 73.32
Debt to Market Cap
 0.00 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
 15.17 14.88 2.32 3.14 3.83
Net Debt to EBITDA
 -1.15 -2.53 -2.13 -3.27 -4.36
Profitability Margins
Gross Profit Margin
40.97%41.60%48.03%57.60%55.63%
EBIT Margin
12.68%9.21%17.04%13.43%10.43%
EBITDA Margin
14.55%11.55%18.19%15.05%12.53%
Operating Profit Margin
11.39%12.54%13.23%14.84%8.65%
Pretax Profit Margin
12.53%9.13%16.95%13.37%10.31%
Net Profit Margin
9.24%6.76%12.47%9.90%7.65%
Continuous Operations Profit Margin
9.24%6.76%12.47%9.90%7.65%
Net Income Per EBT
73.71%74.02%73.57%74.04%74.18%
EBT Per EBIT
110.05%72.79%128.06%90.07%119.22%
Return on Assets (ROA)
12.44%7.62%14.98%10.08%7.19%
Return on Equity (ROE)
26.62%15.02%22.69%16.87%12.05%
Return on Capital Employed (ROCE)
29.58%26.35%23.78%24.78%13.29%
Return on Invested Capital (ROIC)
21.63%19.21%17.41%18.13%9.73%
Return on Tangible Assets
12.44%7.63%15.01%10.08%7.19%
Earnings Yield
0.95%0.55%1.24%1.22%0.97%
Efficiency Ratios
Receivables Turnover
 9.87 9.25 7.65 8.48 9.38
Payables Turnover
 2.33 2.19 3.43 1.87 1.88
Inventory Turnover
 1.65 1.82 2.95 2.24 2.55
Fixed Asset Turnover
 54.65 26.95 19.98 14.29 10.50
Asset Turnover
 1.35 1.13 1.20 1.02 0.94
Working Capital Turnover Ratio
 6.41 2.82 2.52 2.43 2.34
Cash Conversion Cycle
 101.76 73.08 64.71 10.72 -12.36
Days of Sales Outstanding
 37.00 39.45 47.70 43.06 38.91
Days of Inventory Outstanding
 221.43 200.09 123.54 163.26 143.18
Days of Payables Outstanding
 156.67 166.45 106.54 195.59 194.46
Operating Cycle
 258.43 239.54 171.24 206.31 182.09
Cash Flow Ratios
Operating Cash Flow Per Share
 -26.30 26.15 11.15 23.32 40.32
Free Cash Flow Per Share
 -26.42 25.45 6.84 19.91 36.47
CapEx Per Share
 0.12 0.70 4.30 3.41 3.85
Free Cash Flow to Operating Cash Flow
 1.00 0.97 0.61 0.85 0.90
Dividend Paid and CapEx Coverage Ratio
 -0.82 1.06 0.55 2.04 6.89
Capital Expenditure Coverage Ratio
 -226.66 37.35 2.59 6.84 10.48
Operating Cash Flow Coverage Ratio
 -1.89 1.83 6.07 8.08 11.68
Operating Cash Flow to Sales Ratio
 -0.03 0.04 0.02 0.06 0.13
Free Cash Flow Yield
-0.31%0.30%0.13%0.61%1.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 105.75 183.43 80.50 81.90 103.57
Price-to-Sales (P/S) Ratio
 9.77 12.39 10.04 8.11 7.92
Price-to-Book (P/B) Ratio
 26.59 27.56 18.26 13.81 12.48
Price-to-Free Cash Flow (P/FCF) Ratio
 -321.87 333.75 759.88 163.39 69.97
Price-to-Operating Cash Flow Ratio
 -323.19 324.82 466.51 139.51 63.29
Price-to-Earnings Growth (PEG) Ratio
 0.99 -6.48 1.29 1.34 -3.05
Price-to-Fair Value
 26.59 27.56 18.26 13.81 12.48
Enterprise Value Multiple
 66.02 104.80 53.04 50.59 58.85
Enterprise Value
 207.99B 207.30B 125.01B 76.39B 59.40B
EV to EBITDA
 65.75 104.80 53.04 50.59 58.85
EV to Sales
 9.57 12.10 9.65 7.62 7.37
EV to Free Cash Flow
 -315.04 325.88 730.60 153.48 65.14
EV to Operating Cash Flow
 -316.43 317.16 448.53 131.05 58.93
Tangible Book Value Per Share
 319.70 307.90 283.92 235.47 204.56
Shareholders’ Equity Per Share
 319.70 308.16 284.77 235.48 204.56
Tax and Other Ratios
Effective Tax Rate
 0.26 0.26 0.26 0.26 0.26
Revenue Per Share
 870.05 685.37 518.21 401.19 322.24
Net Income Per Share
 80.38 46.30 64.60 39.72 24.64
Tax Burden
 0.74 0.74 0.74 0.74 0.74
Interest Burden
 0.99 0.99 0.99 1.00 0.99
Research & Development to Revenue
 0.00 0.00 0.06 0.00 0.00
SG&A to Revenue
 0.07 0.15 0.03 0.03 0.03
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 -0.26 0.42 0.17 0.43 1.21
Currency in INR